Corrigendum: Screening and characterization of the scFv for chimeric antigen receptor T cells targeting CEA-positive carcinoma

Corrigendum: Screening and characterization of the scFv for chimeric antigen receptor T cells targeting CEA-positive carcinoma

Saved in:

Bibliographic Details
Main Authors:	Chengcheng Zhang, Linling Wang, Qianzhen Zhang, Junjie Shen, Xia Huang, Meiling Wang, Yi Huang, Jun Chen, Yanmin Xu, Wenxu Zhao, Yanan Qi, Yunyan Li, Yanjiao Ou, Zhi Yang, Cheng Qian
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Immunology
Subjects:	chimeric antigen receptor T cells carcinoembryonic antigen single-chain fragment variable affinity cell therapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1548247/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Screening and characterization of the scFv for chimeric antigen receptor T cells targeting CEA-positive carcinoma
by: Chengcheng Zhang, et al.
Published: (2023-05-01)

Diabetic Ketoacidosis in Klinefelter Syndrome Sans Malignancy with Unusually Elevated Levels of CEA: A Case Report
by: Wo X, et al.
Published: (2025-01-01)

Targeting BCMA in multiple myeloma: designs, challenges, and future directions
by: Yi Hu, et al.
Published: (2025-02-01)

Outcomes with bridging radiation therapy prior to chimeric antigen receptor T-cell therapy in patients with aggressive large B-cell lymphomas
by: Gohar S. Manzar, et al.
Published: (2025-01-01)

Unleashing the potential of a low CpG Passer transposon for superior CAR-T cell therapy
by: Jianyao Zeng, et al.
Published: (2025-02-01)

Investigation of the expression level of methylated septin 9 gene and serological carcinoembryonic antigen to diagnose colorectal cancer. A meta-analysis study
by: Sharifeh Jorboniyan, et al.
Published: (2024-12-01)

Real-world use of tafasitamab preceding CD19-directed chimeric antigen receptor T-cell therapy for relapsed or refractory diffuse large B-cell lymphoma
by: Narendranath Epperla, et al.
Published: (2025-01-01)

A case of de novo neuroendocrine prostate cancer presented with elevated level of serum CEA carrying BRCA2 mutation: case report and literature review
by: Weizhe Han, et al.
Published: (2025-01-01)

Lowering the affinity of single-chain monovalent BBB shuttle scFc-scFv8D3 prolongs its half-life and increases brain concentration
by: Andrés de la Rosa, et al.
Published: (2025-01-01)

Quo vadis autoimmune hepatitis? - Summary of the 5th international autoimmune hepatitis group research workshop 2024Keypoints
by: Bastian Engel, et al.
Published: (2025-02-01)

Significance of Baseline and Changes of Tumor Markers and Neutrophil-to-Lymphocyte Ratio in Predicting Overall Survival for Patients with Advanced Pancreatic Adenocarcinoma: A Retrospective Analysis
by: Makoto Kadokura, et al.
Published: (2023-04-01)

scFv Antibody: Principles and Clinical Application
by: Zuhaida Asra Ahmad, et al.
Published: (2012-01-01)

CAR-T therapy for endocrine neoplasms: novel targets and combination of therapies
by: Fang Wang, et al.
Published: (2025-02-01)

Breaking the shield of solid tumors: a combined approach for enhanced efficacy of CAR-T cells
by: Marat Khaliulin, et al.
Published: (2024-11-01)

Clinical outcomes of chimeric antigen receptor T-cell therapy following autologous hematopoietic stem cell transplantation in 38 patients with refractory/relapsed primary or secondary central nervous system lymphoma
by: Jiaying Wu, et al.
Published: (2024-11-01)

Loop33 × 123 CAR-T targeting CD33 and CD123 against immune escape in acute myeloid leukemia
by: Haotian Ma, et al.
Published: (2024-11-01)

Application of adoptive cell therapy in malignant melanoma
by: Qianrong Hu, et al.
Published: (2025-01-01)

Cellular therapies in rheumatic and musculoskeletal diseases
by: Pedro Franco-Fuquen, et al.
Published: (2025-06-01)

Carcinoembryonic antigen trajectory predicts pathological complete response in advanced gastric cancer after neoadjuvant chemotherapy
by: Yonghe Chen, et al.
Published: (2025-02-01)

Management of CAR-T cell therapy in patients with multiple myeloma: a systematic review and expert consensus in Australia
by: P. Joy Ho, et al.
Published: (2025-01-01)

Discovery and in vitro characterization of a human anti-CD36 scFv
by: Cecilia Mata-Cruz, et al.
Published: (2025-02-01)

Differential T cell accumulation within intracranial and subcutaneous melanomas is associated with differences in intratumoral myeloid cells
by: Katarzyna Stasiak, et al.
Published: (2024-11-01)

Efficient chimeric mouse production using a novel embryonic stem cell line
by: G. V. Kontsevaya, et al.
Published: (2017-02-01)

Protease shaving of Mycobacterium tuberculosis facilitates vaccine antigen discovery and delivery of novel cargoes to the Mtb surface
by: Bianca A. Lepe, et al.
Published: (2025-02-01)

Exploring molecular determinants and pharmacokinetic properties of IgG1-scFv bispecific antibodies
by: Kristina M.J. Aertker, et al.
Published: (2024-12-01)

Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis
by: Federica Galvagno, et al.
Published: (2024-11-01)

Large-scale screening of HIV-1 T-cell epitopes restricted by 12 prevalent HLA-A allotypes in Northeast Asia and universal detection of HIV-1-specific CD8+ T cells
by: Yan Ding, et al.
Published: (2025-02-01)

A novel tissue culture method to produce professional antigen-presenting cells from rainbow trout in vitro
by: Nguyen T. K. Vo, PhD, et al.
Published: (2025-06-01)

Exploring new horizons in CAR-based therapy for the treatment of thyroid-associated ophthalmopathy
by: Xin-Yu Zhu, et al.
Published: (2025-01-01)

Detection of chimeric alpha-defensin transcripts and peptides in mouse Paneth cells
by: Steven Timmermans, et al.
Published: (2025-02-01)

A self-activated and protective module enhances the preclinical performance of allogeneic anti-CD70 CAR-T cells
by: Zhao Zhang, et al.
Published: (2025-01-01)

Non-small cell lung cancer and the tumor microenvironment: making headway from targeted therapies to advanced immunotherapy
by: Anna De Lucia, et al.
Published: (2025-02-01)

iPSC Technology Revolutionizes CAR-T Cell Therapy for Cancer Treatment
by: Jiepu Zong, et al.
Published: (2025-01-01)

Novel gene manipulation approaches to unlock the existing bottlenecks of CAR-NK cell therapy
by: Fatemeh Dehghan, et al.
Published: (2025-02-01)

Biparatopic antibodies: therapeutic applications and prospects
by: David L. Niquille, et al.
Published: (2024-12-01)

Prognostic Impact of the Postoperative Carcinoembryonic Antigen Level after Curative Resection of Locally Advanced Rectal Cancer
by: Ryoichi Tsukamoto, et al.
Published: (2025-01-01)

Seq2scFv: a toolkit for the comprehensive analysis of display libraries from long-read sequencing platforms
by: Marianne Bachmann Salvy, et al.
Published: (2024-12-01)

STUDYING IMMUNOBIOLOGICAL CHARACTERISTICS OF FMDV TYPE O ISOLATES RECOVERED IN THE SOUTH KOREA
by: A. A. Funtikov, et al.
Published: (2018-05-01)

Expression of Functional MHC Class II Molecules By aMouse Pro-B Cell Clone
by: Suzanne Lombard-Platet, et al.
Published: (1995-01-01)

New insights into the immunomodulatory potential of sialic acid on monocyte-derived dendritic cells
by: Zélia Silva, et al.
Published: (2024-11-01)